News
Supporting lupus patients and advocates in Arizona.
Researchers from EMD Serono and global collaborators shared promising results from Cohort B of the phase II trial of the WILLOW study.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback